4//SEC Filing
Conover Charles 4
Accession 0000930413-12-003455
CIK 0000727510other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 7:42 PM ET
Size
5.4 KB
Accession
0000930413-12-003455
Insider Transaction Report
Form 4
Conover Charles
SVP, R&D Program Management
Transactions
- Sale
Common Stock
2012-06-05$6.78/sh−25,000$169,500→ 57,213 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.70 to $6.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001538563
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 7:42 PM ET
- Size
- 5.4 KB